The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Memantine hydrochloride Pinewood 10 mg film-coated tablets

Pinewood Laboratories LtdPA0281/166/001

Main Information

Trade NameMemantine hydrochloride Pinewood 10 mg film-coated tablets
Active SubstancesMemantine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/166/001

Group Information

ATC CodeN06DX Other anti-dementia drugs
N06DX01 memantine


License statusAuthorised
Licence Issued18/07/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0022-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back